|
1
|
Kelly PJ: Is osteoporosis a genetically
determined disease? Br J Obstet Gynaecol. 103(Suppl 13): 20–27.
1996.PubMed/NCBI
|
|
2
|
Rossouw JE, Anderson GL, Prentice RL,
LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA,
Howard BV, Johnson KC, et al: Writing Group for the Women's Health
Initiative Investigators: Risks and benefits of estrogen plus
progestin in healthy postmenopausal women: Principal results from
the Woman's Health Initiative randomized controlled trial. JAMA.
288:321–333. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ma DF, Qin LQ, Wang PY and Katoh R: Soy
isoflavone intake inhibits bone resorption and stimulates bone
formation in menopausal women: Meta-analysis of randomized
controlled trials. Eur J Clin Nutr. 62:155–161. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gao SQ, Fu DX and Zhang HM: Advances in
the study on the treatment of osteoporosis with Herba Epimedii and
its compound prescriptions. China J Chin Mater Med. 24:249–251.
1999.
|
|
5
|
Li C, Li Q, Mei Q and Lu T:
Pharmacological effects and pharmacokinetic properties of icariin,
the major bioactive component in Herba Epimedii. Life Sci.
126:57–68. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nian H, Ma MH, Nian SS and Xu LL:
Antiosteoporotic activity of icariin in ovariectomized rats.
Phytomedicine. 16:320–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mok SK, Chen WF, Lai WP, Leung PC, Wang
XL, Yao XS and Wong MS: Icariin protects against bone loss induced
by oestrogen deficiency and activates oestrogen receptor-dependent
osteoblastic functions in UMR 106 cells. Br J Pharmacol.
159:939–949. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pearson J, Dequeker J, Reeve J, Felsenberg
D, Henley M, Bright J, Lunt M, Adams J, Diaz Curiel M and Galan F:
Dual X-ray absorptiometry of the proximal femur: normal European
values standardized with the European Spine Phantom. J Bone Miner
Res. 10:315–324. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fradinho MJ, Vale AC, Bernardes N,
Caldeira RM, Vaz MF and Ferreira-Dias G: Biomechanical properties
of the equine third metacarpal bone: In vivo quantitative
ultrasonography versus ex vivo compression and bending techniques.
J Equine Vet Sci. 35:198–205. 2015. View Article : Google Scholar
|
|
10
|
Effendy NM, Khamis MF and Shuid AN:
Micro-CT assessments of potential anti-osteoporotic agents. Curr
Drug Targets. 14:1542–1551. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Noguchi A, Nakamura K, Sakata K,
Sato-Fukuda N, Ishigaki T, Mano J, Takabatake R, Kitta K, Teshima
R, Kondo K and Nishimaki-Mogami T: Development and interlaboratory
validation of a simple screening method for genetically modified
maize using a DeltaDeltaCq-based multiplex real-time PCR assay.
Analytical Chem. 88:4285–4293. 2016. View Article : Google Scholar
|
|
12
|
Zhang G, Qin L and Shi Y:
Epimedium-derived phytoestrogen flavonoids exert beneficial effect
on preventing bone loss in late postmenopausal women: A 24-month
randomized, double-blind and placebo-controlled trial. J Bone Miner
Res. 22:1072–1079. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ye HY and Lou YJ: Estrogenic effects of
two derivatives of icariin on human breast cancer MCF-7 cells.
Phytomedicine. 12:735–741. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gambacciani M and Levancini M: Hormone
replacement therapy and the prevention of postmenopausal
osteoporosis. Przeglad Menopauzalny. 13:213–220. 2014.PubMed/NCBI
|
|
15
|
Agata U, Park JH, Hattori S, Aikawa Y,
Kakutani Y, Ezawa I, Akimoto T and Omi N: The impact of different
amounts of calcium intake on bone mass and arterial calcification
in ovariectomized rats. J Nutr Sci Vitaminol (Tokyo). 61:391–399.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Einhorn TA: Bone strength: The bottom
line. Calcif Tissue Int. 51:333–339. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma HP, Ming LG, Ge BF, Zhai YK, Song P,
Xian CJ and Chen KM: Icariin is more potent than genistein in
promoting osteoblast differentiation and mineralization in vitro. J
Cell Biochem. 112:916–923. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Evans DB, Bunning RA and Russell RG: The
effects of recombinant human interleukin-1 beta on cellular
proliferation and the production of prostaglandin E2, plasminogen
activator, osteocalcin and alkaline phosphatase by osteoblast-like
cells derived from human bone. Biochem Biophys Res Commun.
166:208–216. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hofbauer LC, Khosla S, Dunstan CR, Lacey
DL, Boyle WJ and Riggs BL: The roles of osteoprotegerin and
osteoprotegerin ligand in the paracrine regulation of bone
resorption. J Bone Miner Res. 15:2–12. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Simonet WS, Lacey DL, Dunstan CR, Kelley
M, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, et
al: Osteoprotegerin: A novel secreted protein involved in the
regulation of bone density. Cell. 89:309–319. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xie GQ, Lei DD, He HB, Gong JJ, Chen C,
Chen P, Zhang H, Luo XH, Liao EY and Wu XP: Relationship between
serum TGF-β1, OPG levels and osteoporotic risk in native Chinese
women. Clinica Chim Acta. 423:116–121. 2013. View Article : Google Scholar
|
|
22
|
Plantalech L, Guillaumont M, Vergnaud P,
Leclercq M and Delmas PD: Impairment of gamma carboxylation of
circulating osteocalcin (bone gla protein) in elderly women. J Bone
Miner Res. 6:1211–1216. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kwan Tat S, Padrines M, Théoleyre S,
Heymann D and Fortun Y: IL-6, RANKL, TNF-alpha/IL-1: Interrelations
in bone resorption pathophysiology. Cytokine Growth Factor Rev.
15:49–60. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qin L, Zhang G, Hung WY, Shi Y, Leung K,
Yeung HY and Leung P: Phytoestrogen-rich herb formula ‘XLGB’
prevents OVX-induced deterioration of musculoskeletal tissues at
the hip in old rats. J Bone Miner Metab. 23(Suppl): S55–S61. 2005.
View Article : Google Scholar
|
|
25
|
Qian G, Zhang X, Lu L, Wu X, Li S and Meng
J: Regulation and of Cbfa1 expression by total flavonoids of Herba
epimedii. Endocr J. 53:87–94. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mok SK, Chen WF, Lai WP, Leung PC, Wang
XL, Yao XS and Wong MS: Icariin protects against bone loss induced
by oestrogen deficiency and activates oestrogen receptor-dependent
osteoblastic functions in UMR 106 cells. Br J Pharmacol.
159:939–949. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Teitelbaum SL: Bone resorption by
osteoclasts. Science. 289:1504–1508. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ahmed Y, Nouri A and Wieschaus E:
Drosophila Apc1 and Apc2 regulate Wingless transduction throughout
development. Development. 129:1751–1762. 2002.PubMed/NCBI
|
|
29
|
Liu C, Li Y, Semenov M, Han C, Baeg GH,
Tan Y, Zhang Z, Lin X and He X: Control of β-Catenin
phosphorylation and degradation by a dual-kinase mechanism. Cell.
108:837–847. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cui Y, Niziolek PJ, MacDonald BT, Zylstra
CR, Alenina N, Robinson DR, Zhong Z, Matthes S, Jacobsen CM, Conlon
RA, et al: Lrp5 functions in bone to regulate bone mass. Nat Med.
17:684–691. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yan Y, Tang D, Chen M, Huang J, Xie R,
Jonason JH, Tan X, Hou W, Reynolds D, Hsu W, et al: Axin2 controls
bone remodeling through the beta-Catenin-BMP signaling pathway in
adult mice. J Cell Sci. 122:3566–3578. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gambardella A, Nagaraju CK, O'Shea PJ,
Mohanty ST, Kottam L, Pilling J, Sullivan M, Djerbi M, Koopmann W,
Croucher PI and Bellantuono I: Glycogen synthase kinase-3α/β
inhibition promotes in vivo amplification of endogenous mesenchymal
progenitors with osteogenic and adipogenic potential and their
differentiation to the osteogenic lineage. J Bone Miner Res.
26:811–821. 2011. View
Article : Google Scholar : PubMed/NCBI
|
